3178 results for «742»
3178 results
Valve in valve - TAV in TAV - Part 2
21 Nov 2023 – From PCR London Valves 2023
Join us for this session, where complex cases shed light on the evolving landscape of valve-in-valve interventions: delve into the efficacy of THV-in-THV for addressing supra-skirtal leakage accompanied by intravascular hemolysis, learn more about the challenges of TAVI-in-TAVI with the deployment of SAPIEN3 Ultra in a...
Treatment of paravalvular leak
21 Nov 2023 – From PCR London Valves 2023
Explore innovative approaches in paravalvular leak management with this selection of cases: discover the unique strategy of employing three plugs to close a challenging mitral paravalvular leak, navigate the challenges of tackling device migration and retrieval in the closure of a sizable aortic paravalvular leak, gain...
TAVI - Coronary complications
21 Nov 2023 – From PCR London Valves 2023
Explore challenging situations in this session: witness the rare occurrence of coronary embolization resulting from a fractured biological surgical valve in an aortic valve-in-valve procedure, uncover the complexities surrounding the late presentation of cardiogenic shock after TAVR, navigate the unusual challenge of intermittent left main obstruction caused...
Mitral valve interventions in challenging clinical situations
21 Nov 2023 – From PCR London Valves 2023
Discover innovative approaches to mitral valve interventions in challenging clinical situations: navigate the challenges of critical stenosis in a bioprosthetic mitral valve, learn more about the use of iVAC-2L in transcatheter edge-to-edge repair for a mitral valve lacking leaflet coaptation, explore mitral transcutaneous edge-to-edge repair guided by transthoracic...
Aortic regurgitation - Part 3
21 Nov 2023 – From PCR London Valves 2023
Consult this session to gain valuable knowledge on approaches to address aortic regurgitation: uncover the clinical effectiveness of TAVR in managing aortic insufficiency associated with LVAD and delve into the comparison between echocardiography and magnetic resonance imaging for assessing device regurgitation in patients undergoing TAVI.
TAVI - Coronary access
21 Nov 2023 – From PCR London Valves 2023
Delve into the complexities of TAVI and coronary access with this session: explore the use of IVUS in assessing coronary arteries at high risk for obstruction following valve-in-valve TAVI, witness the application of patient-specific computer simulation to predict coronary re-access post-TAVI in bicuspid anatomy, navigate the...
Rare complications of structural intervention
21 Nov 2023 – From PCR London Valves 2023
Join us in this session for a look at rare and challenging scenarios in structural interventions: delve into the complexities of an ascending aorta mycotic aneurysm in a patient with a prior TAVI procedure, witness a unique case showcasing a misloaded self-expanding TAVR device, uncover the...
Prevention and treatment of left ventricular outflow tract obstruction
19 Nov 2023 – From PCR London Valves 2023
Explore intriguing cases in this session and gain a deeper understanding of preventing and managing LVOT obstruction: uncover innovative approaches such as Valve-in-Valve TMVR with Lampoon, learn about the nuances of TMVR after re-section of the anterior leaflet, and more!
Transcatheter mitral repair and replacement for primary mitral regurgitation - LIVE case
19 Nov 2023 – From PCR London Valves 2023
This session aims to highlight the remarkable advancements achieved in transcatheter mitral valve intervention over the past two decades, since its inception. Follow two TEER cases which illustrate this rapidly growing field:
- Transcatheter edge-edge mitral valve repair
A 77-year-old male with a history of SAVR (bioprothesis) + LIM-LAD/Diag, normal...
Key questions in mitral valve intervention - What do I need to know about imaging?
19 Nov 2023 – From PCR London Valves 2023
Explore the crucial aspects of imaging in mitral valve intervention with a focus on the entire treatment pathway, from patient selection to post-procedural follow-up. Gain insights into optimizing patient selection for mitral valve edge-to-edge repair and replacement, and learn key views essential for optimal imaging and...
Contemporary approach in the treatment of calcified coronary artery disease
28 Feb 2026 – From Euro4C Annual Meeting 2026
Adopt a contemporary approach to managing calcified coronary artery disease by leveraging high-definition IVUS for lesion assessment and morphology evaluation. Learn to tailor calcium modification strategies based on IVUS findings and combine available tools to optimize treatment outcomes according to patient and lesion profiles.
TEER in complex tricuspid regurgitation - LIVE case
14 Feb 2026 – From PCR Tokyo Valves 2026
A 79-year-old male with permanent AF, prior colorectal and prostate cancer, and a Mosaic bioprosthetic mitral valve implanted in 2016, presented with torrential tricuspid regurgitation and preserved LV function.
Three G5 clips were implanted: two anteroseptal (1 XTW and 1 XT) and one posteroseptal XTW.
LIVE Educational Case...
Primary mitral TEER in small anatomy - LIVE case
15 Feb 2026 – From PCR Tokyo Valves 2026
An 89-year-old male with diabetes mellitus, hypertension, chronic kidney disease (eGFR: 46), and CAD with a history of NSTEMI and CTO of the RCA, presented with symptomatic primary mitral regurgitation (P1–P2 prolapse) and preserved LV function (56%).
One Pascal ACE device was implanted.
LIVE Educational Case from Nagoya...
Mitral and aortic transcatheter valve-in-valve intervention - LIVE case
14 Feb 2026 – From PCR Tokyo Valves 2026
Live case
An 83-year-old male with AF, CKD (stage 3A), preserved LV function, and a history of AVR (27 mm Magna Ease) and MVR (33 mm Magna) in 2014 presented with symptomatic stenosis of the mitral bioprosthesis. A Sapien 3 valve was implanted in the Magna mitral...
PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial
18 May 2021
Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for...
A large-scale, randomized trial of orbital atherectomy vs. conventional balloon angioplasty in severely calcified coronary arteries prior to DES implantation (ECLIPSE)
30 Oct 2024
Nicola Ryan provides her take on the ECLIPSE trial presented by Ajay J. Kirtane at TCT 2024 in Washington.
Author
30 years of primary PCI – a tale of perseverance
16 May 2023
Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.
ILUMIEN IV: OPTIMAL PCI - Optical Coherence Tomography Guided Coronary Stent Implantation Compared with Angiography: A Multicenter Randomized Trial in Percutaneous Coronary Intervention
29 Aug 2023
Claudio Laudani and Daniele Giacoppo report the main results of the ILUMIEN IV trial presented by Ziad Ali, from the St. Francis Hospital, Roslyn, and Clinical Trials Center, Cardiovascular Research Foundation, New York, in a Hot Line session at the European Society of Cardiology congress 2023...
Author
Author
